AmCham EU stands in solidarity with the European Commission’s Beating Cancer Plan

Cancer is the second leading cause of death worldwide. In Europe, 2.6 million people are diagnosed with cancer every year, with nearly half of that number succumbing to the disease. If decisive action is not taken, then by 2035, approximately 40% of Europeans can expect to face cancer in their lifetime.

On this year’s World Cancer Day, AmCham EU stands in solidarity with the European Commission’s Beating Cancer Plan. Several of our member companies directly contribute to the fight against cancer providing innovative solutions in the form of cancer treatments or developing the medical devices used in cancer diagnosis.

News

3 Feb 2021

Healthcare

HomePolicy and newsLibraryAmCham EU stands in solidarity with the European Commission’s Beating Cancer Plan

With this ambitious plan, the EU has devised a four-pillar approach to overcome cancer as a leading cause of death. These are:

prevention;
early detection;
diagnosis and treatment; and
quality of life of cancer patients and survivors.

AmCham EU shares the European Commission’s ambition to take on cancer. A holistic approach that encompasses the entire disease pathway, while engaging the full arsenal of the life sciences sector in the fight, can help to improve the survival chances of cancer patients, while reducing the number of cases.

Check out our explainer of Europe’s Beating Cancer Plan.

Related items

News

20 May 2026

Healthcare, competitiveness, innovation and simplification

Europe’s life sciences sector sits at the heart of the EU’s competitiveness agenda. It supports advanced manufacturing and helps bring new treatments and technologies to patients. Yet companies deciding where to invest need a regulatory environment that is predictable and open to global cooperation.

The European Commission’s work on the Biotech Act and the targeted revision of the Medical Devices and In Vitro Diagnostics Regulations (MDR/IVDR) offers an opportunity to improve that environment. Both files can help make Europe a stronger location for life sciences investment.

The EU should use this moment to build a framework that keeps pace with scientific progress. That means faster and clearer procedures. It also means better use of data and intellectual property rules that recognise the realities of global supply chains.

Healthcare

Simplification